1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CELLECTIS - ADR
4.26 -0.15 (-3.40%)
24,860
XNAS Volume

XNAS 12 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Cellectis (ADR) - CLLS - stock price prediction, stock price target, analyst ratings from 6 analysts

Cellectis (ADR) has a share price target of US$ 7, revenue growth forecast of 55.7%, and profit growth estimate of -94.8% for FY25, based on top 6 analyst calls.